Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 81

1.

Significance of Interstitial Lung Disease on Outcomes Following Cardiac Surgery.

Hirji SA, Ramirez-Del Val F, Ejiofor JI, Lee J, Norman AV, McGurk S, Pelletier MP, Aranki S, Rawn J, Shekar PS, Hunninghake GM, Kaneko T.

Am J Cardiol. 2019 Oct 1;124(7):1133-1139. doi: 10.1016/j.amjcard.2019.06.031. Epub 2019 Jul 17.

PMID:
31405546
2.

Ambient air pollution exposure and risk and progression of interstitial lung abnormalities: the Framingham Heart Study.

Rice MB, Li W, Schwartz J, Di Q, Kloog I, Koutrakis P, Gold DR, Hallowell RW, Zhang C, O'Connor G, Washko GR, Hunninghake GM, Mittleman MA.

Thorax. 2019 Aug 7. pii: thoraxjnl-2018-212877. doi: 10.1136/thoraxjnl-2018-212877. [Epub ahead of print]

PMID:
31391318
3.

Overlap of Genetic Risk Between Interstitial Lung Abnormalities and Idiopathic Pulmonary Fibrosis.

Hobbs BD, Putman RK, Araki T, Nishino M, Gudmundsson G, Gudnason V, Eiriksdottir G, Zilhao Nogueira NR, Dupuis J, Xu H, O'Connor GT, Manichaikul A, Nguyen J, Podolanczuk AJ, Madahar P, Rotter JI, Lederer DJ, Barr RG, Rich SS, Ampleford EJ, Ortega VE, Peters SP, O'Neal WK, Newell JD Jr, Bleecker ER, Meyers DA, Allen RJ, Oldham JM, Ma SF, Noth I, Jenkins RG, Maher TM, Hubbard RB, Wain LV, Fingerlin TE, Schwartz DA, Washko GR, Rosas IO, Silverman EK, Hatabu H, Cho MH, Hunninghake GM; COPDGene Investigators, ECLIPSE Investigators, SPIROMICS Research Group, and UK ILD Consortium.

Am J Respir Crit Care Med. 2019 Jul 24. doi: 10.1164/rccm.201903-0511OC. [Epub ahead of print]

PMID:
31339356
4.

Objectively Measured Chronic Lung Injury on Chest CT.

Harmouche R, Ash SY, Putman RK, Hunninghake GM, San Jose Estepar R, Martinez FJ, Choi AM, Lynch DA, Hatabu H, Han MK, Bowler RP, Kalhan R, Rosas IO, Washko GR, San Jose Estepar R; COPDGene Investigators.

Chest. 2019 Jun 22. pii: S0012-3692(19)31197-3. doi: 10.1016/j.chest.2019.05.020. [Epub ahead of print]

PMID:
31233744
5.

Association of Elevated Plasma Interleukin-18 Level With Increased Mortality in a Clinical Trial of Statin Treatment for Acute Respiratory Distress Syndrome.

Rogers AJ, Guan J, Trtchounian A, Hunninghake GM, Kaimal R, Desai M, Kozikowski LA, DeSouza L, Mogan S, Liu KD, Matthay MA, Steingrub J, Wheeler A, Yoon JH, Nakahira K, Choi AM, Baron RM.

Crit Care Med. 2019 Aug;47(8):1089-1096. doi: 10.1097/CCM.0000000000003816.

PMID:
31206358
6.

Rituximab Monotherapy for Common Variable Immune Deficiency-Associated Granulomatous-Lymphocytic Interstitial Lung Disease.

Ng J, Wright K, Alvarez M, Hunninghake GM, Wesemann DR.

Chest. 2019 May;155(5):e117-e121. doi: 10.1016/j.chest.2019.01.034.

PMID:
31060706
7.

Exploring the cross-phenotype network region of disease modules reveals concordant and discordant pathways between chronic obstructive pulmonary disease and idiopathic pulmonary fibrosis.

Halu A, Liu S, Baek SH, Hobbs BD, Hunninghake GM, Cho MH, Silverman EK, Sharma A.

Hum Mol Genet. 2019 Jul 15;28(14):2352-2364. doi: 10.1093/hmg/ddz069.

PMID:
30997486
8.

Gasping for a Diagnosis.

D'Silva K, Brown S, Hunninghake GM, Vivero M, Loscalzo J.

N Engl J Med. 2019 Mar 7;380(10):961-967. doi: 10.1056/NEJMcps1809942. No abstract available.

PMID:
30855747
9.

Interstitial lung abnormalities: erecting fences in the path towards advanced pulmonary fibrosis.

Hunninghake GM.

Thorax. 2019 May;74(5):506-511. doi: 10.1136/thoraxjnl-2018-212446. Epub 2019 Feb 5.

10.

Imaging Patterns Are Associated with Interstitial Lung Abnormality Progression and Mortality.

Putman RK, Gudmundsson G, Axelsson GT, Hida T, Honda O, Araki T, Yanagawa M, Nishino M, Miller ER, Eiriksdottir G, Gudmundsson EF, Tomiyama N, Honda H, Rosas IO, Washko GR, Cho MH, Schwartz DA, Gudnason V, Hatabu H, Hunninghake GM.

Am J Respir Crit Care Med. 2019 Jul 15;200(2):175-183. doi: 10.1164/rccm.201809-1652OC.

PMID:
30673508
11.

Incidental nonneoplastic parenchymal findings in patients undergoing lung resection for mass lesions.

Hung YP, Hunninghake GM, Miller ER, Putman R, Nishino M, Araki T, Hatabu H, Sholl LM, Vivero M.

Hum Pathol. 2019 Apr;86:93-101. doi: 10.1016/j.humpath.2019.01.002. Epub 2019 Jan 15.

PMID:
30658062
12.

Interstitial Lung Abnormality: Recognition and Perspectives.

Hatabu H, Hunninghake GM, Lynch DA.

Radiology. 2019 Apr;291(1):1-3. doi: 10.1148/radiol.2018181684. Epub 2018 Dec 18. No abstract available.

PMID:
30561274
13.

Increased Airway Wall Thickness in Interstitial Lung Abnormalities and Idiopathic Pulmonary Fibrosis.

Miller ER, Putman RK, Diaz AA, Xu H, San José Estépar R, Araki T, Nishino M, Poli de Frías S, Hida T, Ross J, Coxson H, Dupuis J, O'Connor GT, Silverman EK, Rosas IO, Hatabu H, Washko G, Hunninghake GM.

Ann Am Thorac Soc. 2019 Apr;16(4):447-454. doi: 10.1513/AnnalsATS.201806-424OC.

PMID:
30543456
14.

Interstitial lung abnormalities and physical function.

Axelsson GT, Putman RK, Miller ER, Araki T, Sigurdsson S, Gudmundsson EF, Eiríksdottír G, Siggeirsdottir K, Aspelund T, Launer LJ, Harris TB, Hatabu H, Gudnason V, Hunninghake GM, Gudmundsson G.

ERJ Open Res. 2018 Sep 3;4(3). pii: 00057-2018. doi: 10.1183/23120541.00057-2018. eCollection 2018 Jul.

15.

MUC5B Promoter Polymorphism and Development of Acute Respiratory Distress Syndrome.

Rogers AJ, Solus JF, Hunninghake GM, Baron RM, Meyer NJ, Janz DR, Schwartz DA, May AK, Lawson WE, Blackwell TS, Ware LB.

Am J Respir Crit Care Med. 2018 Nov 15;198(10):1342-1345. doi: 10.1164/rccm.201801-0140LE. No abstract available.

PMID:
30025215
16.

Interstitial Features at Chest CT Enhance the Deleterious Effects of Emphysema in the COPDGene Cohort.

Ash SY, Harmouche R, Ross JC, Diaz AA, Rahaghi FN, Vegas Sanchez-Ferrero G, Putman RK, Hunninghake GM, Onieva Onieva J, Martinez FJ, Choi AM, Bowler RP, Lynch DA, Hatabu H, Bhatt SP, Dransfield MT, Wells JM, Rosas IO, San Jose Estepar R, Washko GR; COPDGene Investigators.

Radiology. 2018 Aug;288(2):600-609. doi: 10.1148/radiol.2018172688. Epub 2018 Jun 5.

17.

Association between acute respiratory disease events and the MUC5B promoter polymorphism in smokers.

Ash SY, Harmouche R, Putman RK, Ross JC, Martinez FJ, Choi AM, Bowler RP, Regan EA, Curtis JL, Han MK, Boucher RC, O'Neal WK, Hatabu H, Lynch DA, Rosas IO, Hunninghake GM, San Jose Estepar R, Washko GR; COPDGene Investigators.

Thorax. 2018 Nov;73(11):1071-1074. doi: 10.1136/thoraxjnl-2017-211208. Epub 2018 Feb 13.

PMID:
29440587
18.

Interstitial lung abnormalities and self-reported health and functional status.

Axelsson GT, Putman RK, Araki T, Sigurdsson S, Gudmundsson EF, Eiriksdottir G, Aspelund T, Miller ER, Launer LJ, Harris TB, Hatabu H, Gudnason V, Hunninghake GM, Gudmundsson G.

Thorax. 2018 Sep;73(9):884-886. doi: 10.1136/thoraxjnl-2017-210956. Epub 2018 Jan 9.

19.

Malaria and the development of pulmonary fibrosis.

Miller ER, Hunninghake GM.

Eur Respir J. 2017 Dec 7;50(6). pii: 1702030. doi: 10.1183/13993003.02030-2017. Print 2017 Dec. No abstract available.

20.

Author reply: 'Response to: Pleural abnormalities in the Framingham Heart Study: prevalence and CT image features' by Araki et al.

Araki T, Hunninghake GM, Christiani DC, Hatabu H.

Occup Environ Med. 2018 Jan;75(1):77-78. doi: 10.1136/oemed-2017-104823. Epub 2017 Nov 9. No abstract available.

PMID:
29122924
21.

A Phase II Clinical Trial of Low-Dose Inhaled Carbon Monoxide in Idiopathic Pulmonary Fibrosis.

Rosas IO, Goldberg HJ, Collard HR, El-Chemaly S, Flaherty K, Hunninghake GM, Lasky JA, Lederer DJ, Machado R, Martinez FJ, Maurer R, Teller D, Noth I, Peters E, Raghu G, Garcia JGN, Choi AMK.

Chest. 2018 Jan;153(1):94-104. doi: 10.1016/j.chest.2017.09.052. Epub 2017 Oct 31.

22.

Disease Severity Dependence of the Longitudinal Association Between CT Lung Density and Lung Function in Smokers.

Diaz AA, Strand M, Coxson HO, Ross JC, San Jose Estepar R, Lynch D, van Rikxoort EM, Rosas IO, Hunninghake GM, Putman RK, Hatabu H, Yen A, Kinney GL, Hokanson JE, Silverman EK, Crapo J, Washko GR.

Chest. 2018 Mar;153(3):638-645. doi: 10.1016/j.chest.2017.10.012. Epub 2017 Oct 21.

23.

Histopathology of Interstitial Lung Abnormalities in the Context of Lung Nodule Resections.

Miller ER, Putman RK, Vivero M, Hung Y, Araki T, Nishino M, Washko GR, Rosas IO, Hatabu H, Sholl LM, Hunninghake GM.

Am J Respir Crit Care Med. 2018 Apr 1;197(7):955-958. doi: 10.1164/rccm.201708-1679LE. No abstract available.

24.

The MUC5B promoter polymorphism is associated with specific interstitial lung abnormality subtypes.

Putman RK, Gudmundsson G, Araki T, Nishino M, Sigurdsson S, Gudmundsson EF, Eiríksdottír G, Aspelund T, Ross JC, San José Estépar R, Miller ER, Yamada Y, Yanagawa M, Tomiyama N, Launer LJ, Harris TB, El-Chemaly S, Raby BA, Cho MH, Rosas IO, Washko GR, Schwartz DA, Silverman EK, Gudnason V, Hatabu H, Hunninghake GM.

Eur Respir J. 2017 Sep 11;50(3). pii: 1700537. doi: 10.1183/13993003.00537-2017. Print 2017 Sep.

25.

Genome-wide association study of subclinical interstitial lung disease in MESA.

Manichaikul A, Wang XQ, Sun L, Dupuis J, Borczuk AC, Nguyen JN, Raghu G, Hoffman EA, Onengut-Gumuscu S, Farber EA, Kaufman JD, Rabinowitz D, Stukovsky KDH, Kawut SM, Hunninghake GM, Washko GR, O'Connor GT, Rich SS, Barr RG, Lederer DJ.

Respir Res. 2017 May 18;18(1):97. doi: 10.1186/s12931-017-0581-2.

26.

Clinical and Genetic Associations of Objectively Identified Interstitial Changes in Smokers.

Ash SY, Harmouche R, Putman RK, Ross JC, Diaz AA, Hunninghake GM, Onieva Onieva J, Martinez FJ, Choi AM, Lynch DA, Hatabu H, Rosas IO, San Jose Estepar R, Washko GR; COPDGene Investigators.

Chest. 2017 Oct;152(4):780-791. doi: 10.1016/j.chest.2017.04.185. Epub 2017 May 12.

27.

Pleural abnormalities in the Framingham Heart Study: prevalence and CT image features.

Araki T, Yanagawa M, Sun FJ, Dupuis J, Nishino M, Yamada Y, Washko GR, Christiani DC, Tomiyama N, O'Connor GT, Hunninghake GM, Hatabu H.

Occup Environ Med. 2017 Oct;74(10):756-761. doi: 10.1136/oemed-2016-104178. Epub 2017 May 3.

28.

Densitometric and local histogram based analysis of computed tomography images in patients with idiopathic pulmonary fibrosis.

Ash SY, Harmouche R, Vallejo DL, Villalba JA, Ostridge K, Gunville R, Come CE, Onieva Onieva J, Ross JC, Hunninghake GM, El-Chemaly SY, Doyle TJ, Nardelli P, Sanchez-Ferrero GV, Goldberg HJ, Rosas IO, San Jose Estepar R, Washko GR.

Respir Res. 2017 Mar 7;18(1):45. doi: 10.1186/s12931-017-0527-8.

29.

Interstitial Lung Abnormalities Are Associated with Acute Respiratory Distress Syndrome.

Putman RK, Hunninghake GM, Dieffenbach PB, Barragan-Bradford D, Serhan K, Adams U, Hatabu H, Nishino M, Padera RF, Fredenburgh LE, Baron RM, Englert JA.

Am J Respir Crit Care Med. 2017 Jan 1;195(1):138-141. doi: 10.1164/rccm.201604-0818LE. No abstract available.

30.

The Objective Identification and Quantification of Interstitial Lung Abnormalities in Smokers.

Ash SY, Harmouche R, Ross JC, Diaz AA, Hunninghake GM, Putman RK, Onieva J, Martinez FJ, Choi AM, Lynch DA, Hatabu H, Rosas IO, Estepar RSJ, Washko GR.

Acad Radiol. 2017 Aug;24(8):941-946. doi: 10.1016/j.acra.2016.08.023. Epub 2016 Dec 15.

31.

Association of Donor and Recipient Telomere Length with Clinical Outcomes following Lung Transplantation.

Courtwright AM, Fried S, Villalba JA, Moniodis A, Guleria I, Wood I, Milford E, Mallidi HH, Hunninghake GM, Raby BA, Agarwal S, Camp PC, Rosas IO, Goldberg HJ, El-Chemaly S.

PLoS One. 2016 Sep 2;11(9):e0162409. doi: 10.1371/journal.pone.0162409. eCollection 2016.

32.

Development and Progression of Interstitial Lung Abnormalities in the Framingham Heart Study.

Araki T, Putman RK, Hatabu H, Gao W, Dupuis J, Latourelle JC, Nishino M, Zazueta OE, Kurugol S, Ross JC, San José Estépar R, Schwartz DA, Rosas IO, Washko GR, O'Connor GT, Hunninghake GM.

Am J Respir Crit Care Med. 2016 Dec 15;194(12):1514-1522.

33.

Association Between Interstitial Lung Abnormalities and All-Cause Mortality.

Putman RK, Hatabu H, Araki T, Gudmundsson G, Gao W, Nishino M, Okajima Y, Dupuis J, Latourelle JC, Cho MH, El-Chemaly S, Coxson HO, Celli BR, Fernandez IE, Zazueta OE, Ross JC, Harmouche R, Estépar RS, Diaz AA, Sigurdsson S, Gudmundsson EF, Eiríksdottír G, Aspelund T, Budoff MJ, Kinney GL, Hokanson JE, Williams MC, Murchison JT, MacNee W, Hoffmann U, O'Donnell CJ, Launer LJ, Harrris TB, Gudnason V, Silverman EK, O'Connor GT, Washko GR, Rosas IO, Hunninghake GM; Evaluation of COPD Longitudinally to Identify Predictive Surrogate Endpoints (ECLIPSE) Investigators; COPDGene Investigators.

JAMA. 2016 Feb 16;315(7):672-81. doi: 10.1001/jama.2016.0518.

34.

Galectin-3 Is Associated with Restrictive Lung Disease and Interstitial Lung Abnormalities.

Ho JE, Gao W, Levy D, Santhanakrishnan R, Araki T, Rosas IO, Hatabu H, Latourelle JC, Nishino M, Dupuis J, Washko GR, O'Connor GT, Hunninghake GM.

Am J Respir Crit Care Med. 2016 Jul 1;194(1):77-83. doi: 10.1164/rccm.201509-1753OC.

35.

A comparison of visual and quantitative methods to identify interstitial lung abnormalities.

Kliment CR, Araki T, Doyle TJ, Gao W, Dupuis J, Latourelle JC, Zazueta OE, Fernandez IE, Nishino M, Okajima Y, Ross JC, Estépar RS, Diaz AA, Lederer DJ, Schwartz DA, Silverman EK, Rosas IO, Washko GR, O'Connor GT, Hatabu H, Hunninghake GM.

BMC Pulm Med. 2015 Oct 29;15:134. doi: 10.1186/s12890-015-0124-x.

36.

Pulmonary cysts identified on chest CT: are they part of aging change or of clinical significance?

Araki T, Nishino M, Gao W, Dupuis J, Putman RK, Washko GR, Hunninghake GM, O'Connor GT, Hatabu H.

Thorax. 2015 Dec;70(12):1156-62. doi: 10.1136/thoraxjnl-2015-207653. Epub 2015 Oct 29.

37.

Normal thymus in adults: appearance on CT and associations with age, sex, BMI and smoking.

Araki T, Nishino M, Gao W, Dupuis J, Hunninghake GM, Murakami T, Washko GR, O'Connor GT, Hatabu H.

Eur Radiol. 2016 Jan;26(1):15-24. doi: 10.1007/s00330-015-3796-y. Epub 2015 Apr 30.

38.

Paraseptal emphysema: Prevalence and distribution on CT and association with interstitial lung abnormalities.

Araki T, Nishino M, Zazueta OE, Gao W, Dupuis J, Okajima Y, Latourelle JC, Rosas IO, Murakami T, O'Connor GT, Washko GR, Hunninghake GM, Hatabu H.

Eur J Radiol. 2015 Jul;84(7):1413-8. doi: 10.1016/j.ejrad.2015.03.010. Epub 2015 Mar 18.

39.

Detection of Rheumatoid Arthritis-Interstitial Lung Disease Is Enhanced by Serum Biomarkers.

Doyle TJ, Patel AS, Hatabu H, Nishino M, Wu G, Osorio JC, Golzarri MF, Traslosheros A, Chu SG, Frits ML, Iannaccone CK, Koontz D, Fuhrman C, Weinblatt ME, El-Chemaly SY, Washko GR, Hunninghake GM, Choi AM, Dellaripa PF, Oddis CV, Shadick NA, Ascherman DP, Rosas IO.

Am J Respir Crit Care Med. 2015 Jun 15;191(12):1403-12. doi: 10.1164/rccm.201411-1950OC.

40.

Anterior Mediastinal Masses in the Framingham Heart Study: Prevalence and CT Image Characteristics.

Araki T, Nishino M, Gao W, Dupuis J, Washko GR, Hunninghake GM, Murakami T, O'Connor GT, Hatabu H.

Eur J Radiol Open. 2015;2:26-31.

41.

A first glimpse at the early origins of idiopathic pulmonary fibrosis.

Eickelberg O, Hunninghake GM.

Am J Respir Crit Care Med. 2015 Feb 15;191(4):366-8. doi: 10.1164/rccm.201412-2187ED. No abstract available.

42.

Short telomeres, telomeropathy, and subclinical extrapulmonary organ damage in patients with interstitial lung disease.

George G, Rosas IO, Cui Y, McKane C, Hunninghake GM, Camp PC, Raby BA, Goldberg HJ, El-Chemaly S.

Chest. 2015 Jun;147(6):1549-1557. doi: 10.1378/chest.14-0631.

43.

Circadian rhythm reprogramming during lung inflammation.

Haspel JA, Chettimada S, Shaik RS, Chu JH, Raby BA, Cernadas M, Carey V, Process V, Hunninghake GM, Ifedigbo E, Lederer JA, Englert J, Pelton A, Coronata A, Fredenburgh LE, Choi AM.

Nat Commun. 2014 Sep 11;5:4753. doi: 10.1038/ncomms5753.

44.

DNAH5 is associated with total lung capacity in chronic obstructive pulmonary disease.

Lee JH, McDonald ML, Cho MH, Wan ES, Castaldi PJ, Hunninghake GM, Marchetti N, Lynch DA, Crapo JD, Lomas DA, Coxson HO, Bakke PS, Silverman EK, Hersh CP; COPDGene and ECLIPSE Investigators.

Respir Res. 2014 Aug 20;15:97. doi: 10.1186/s12931-014-0097-y.

45.

A new hope for idiopathic pulmonary fibrosis.

Hunninghake GM.

N Engl J Med. 2014 May 29;370(22):2142-3. doi: 10.1056/NEJMe1403448. Epub 2014 May 18. No abstract available.

PMID:
24836311
46.

Genetics and early detection in idiopathic pulmonary fibrosis.

Putman RK, Rosas IO, Hunninghake GM.

Am J Respir Crit Care Med. 2014 Apr 1;189(7):770-8. doi: 10.1164/rccm.201312-2219PP. Review.

47.

Metabolomic derangements are associated with mortality in critically ill adult patients.

Rogers AJ, McGeachie M, Baron RM, Gazourian L, Haspel JA, Nakahira K, Fredenburgh LE, Hunninghake GM, Raby BA, Matthay MA, Otero RM, Fowler VG, Rivers EP, Woods CW, Kingsmore S, Langley RJ, Choi AM.

PLoS One. 2014 Jan 30;9(1):e87538. doi: 10.1371/journal.pone.0087538. eCollection 2014.

48.

Circulating mitochondrial DNA in patients in the ICU as a marker of mortality: derivation and validation.

Nakahira K, Kyung SY, Rogers AJ, Gazourian L, Youn S, Massaro AF, Quintana C, Osorio JC, Wang Z, Zhao Y, Lawler LA, Christie JD, Meyer NJ, Mc Causland FR, Waikar SS, Waxman AB, Chung RT, Bueno R, Rosas IO, Fredenburgh LE, Baron RM, Christiani DC, Hunninghake GM, Choi AM.

PLoS Med. 2013 Dec;10(12):e1001577; discussion e1001577. doi: 10.1371/journal.pmed.1001577. Epub 2013 Dec 31.

49.

Functional impact of a spectrum of interstitial lung abnormalities in rheumatoid arthritis.

Doyle TJ, Dellaripa PF, Batra K, Frits ML, Iannaccone CK, Hatabu H, Nishino M, Weinblatt ME, Ascherman DP, Washko GR, Hunninghake GM, Choi AMK, Shadick NA, Rosas IO.

Chest. 2014 Jul;146(1):41-50. doi: 10.1378/chest.13-1394.

50.

Interstitial pneumonitis and the risk of chronic allograft rejection in lung transplant recipients.

Mihalek AD, Rosas IO, Padera RF Jr, Fuhlbrigge AL, Hunninghake GM, DeMeo DL, Camp PC Jr, Goldberg HJ.

Chest. 2013 May;143(5):1430-1435. doi: 10.1378/chest.12-0354.

Supplemental Content

Loading ...
Support Center